Complete response to paclitaxel, ifosfamide, and cisplatin therapy in a case of ovarian ependymoma

Makiko Hino, Yusuke Kobayashi, Michiko Wada, Yoshihisa Hattori, Takashi Kurahasi, Hiroyuki Nakagawa

Research output: Contribution to journalArticle

3 Citations (Scopus)

Abstract

There are many reports on paclitaxel, ifosfamide, and cisplatin (TIP) therapy, following standard bleomycin, etoposide, and cisplatin (BEP) therapy, for salvage treatment of testicular malignant germ cell tumors, but there are no reports on its use for ovarian malignant tumors. We report here that a patient with primary ependymoma of the ovary, who was resistant to BEP therapy, achieved a complete response to a combined therapy, including TIP therapy as the second-line chemotherapy and surgery. This important case, combined with published studies, suggests that TIP therapy is effective for both testicular and ovarian malignant tumors and indicates that TIP therapy can be used as an effective second-line therapy for malignant tumors resistant to BEP therapy.

Original languageEnglish
Pages (from-to)1613-1617
Number of pages5
JournalJournal of Obstetrics and Gynaecology Research
Volume42
Issue number11
DOIs
Publication statusPublished - 2016 Nov 1

Fingerprint

Ependymoma
Ifosfamide
Bleomycin
Etoposide
Cisplatin
Therapeutics
TP protocol
Salvage Therapy
Neoplasms
Ovary
Drug Therapy

Keywords

  • bleomycin, etoposide, and cisplatin
  • ependymoma
  • malignant germ cell tumors
  • paclitaxel, ifosfamide, and cisplatin
  • salvage

ASJC Scopus subject areas

  • Obstetrics and Gynaecology

Cite this

Complete response to paclitaxel, ifosfamide, and cisplatin therapy in a case of ovarian ependymoma. / Hino, Makiko; Kobayashi, Yusuke; Wada, Michiko; Hattori, Yoshihisa; Kurahasi, Takashi; Nakagawa, Hiroyuki.

In: Journal of Obstetrics and Gynaecology Research, Vol. 42, No. 11, 01.11.2016, p. 1613-1617.

Research output: Contribution to journalArticle

Hino, Makiko ; Kobayashi, Yusuke ; Wada, Michiko ; Hattori, Yoshihisa ; Kurahasi, Takashi ; Nakagawa, Hiroyuki. / Complete response to paclitaxel, ifosfamide, and cisplatin therapy in a case of ovarian ependymoma. In: Journal of Obstetrics and Gynaecology Research. 2016 ; Vol. 42, No. 11. pp. 1613-1617.
@article{11059854396e40a99669deb1676ab2e2,
title = "Complete response to paclitaxel, ifosfamide, and cisplatin therapy in a case of ovarian ependymoma",
abstract = "There are many reports on paclitaxel, ifosfamide, and cisplatin (TIP) therapy, following standard bleomycin, etoposide, and cisplatin (BEP) therapy, for salvage treatment of testicular malignant germ cell tumors, but there are no reports on its use for ovarian malignant tumors. We report here that a patient with primary ependymoma of the ovary, who was resistant to BEP therapy, achieved a complete response to a combined therapy, including TIP therapy as the second-line chemotherapy and surgery. This important case, combined with published studies, suggests that TIP therapy is effective for both testicular and ovarian malignant tumors and indicates that TIP therapy can be used as an effective second-line therapy for malignant tumors resistant to BEP therapy.",
keywords = "bleomycin, etoposide, and cisplatin, ependymoma, malignant germ cell tumors, paclitaxel, ifosfamide, and cisplatin, salvage",
author = "Makiko Hino and Yusuke Kobayashi and Michiko Wada and Yoshihisa Hattori and Takashi Kurahasi and Hiroyuki Nakagawa",
year = "2016",
month = "11",
day = "1",
doi = "10.1111/jog.13084",
language = "English",
volume = "42",
pages = "1613--1617",
journal = "Asia-Oceania Journal of Obstetrics and Gynaecology",
issn = "1341-8076",
publisher = "Blackwell Publishing Asia",
number = "11",

}

TY - JOUR

T1 - Complete response to paclitaxel, ifosfamide, and cisplatin therapy in a case of ovarian ependymoma

AU - Hino, Makiko

AU - Kobayashi, Yusuke

AU - Wada, Michiko

AU - Hattori, Yoshihisa

AU - Kurahasi, Takashi

AU - Nakagawa, Hiroyuki

PY - 2016/11/1

Y1 - 2016/11/1

N2 - There are many reports on paclitaxel, ifosfamide, and cisplatin (TIP) therapy, following standard bleomycin, etoposide, and cisplatin (BEP) therapy, for salvage treatment of testicular malignant germ cell tumors, but there are no reports on its use for ovarian malignant tumors. We report here that a patient with primary ependymoma of the ovary, who was resistant to BEP therapy, achieved a complete response to a combined therapy, including TIP therapy as the second-line chemotherapy and surgery. This important case, combined with published studies, suggests that TIP therapy is effective for both testicular and ovarian malignant tumors and indicates that TIP therapy can be used as an effective second-line therapy for malignant tumors resistant to BEP therapy.

AB - There are many reports on paclitaxel, ifosfamide, and cisplatin (TIP) therapy, following standard bleomycin, etoposide, and cisplatin (BEP) therapy, for salvage treatment of testicular malignant germ cell tumors, but there are no reports on its use for ovarian malignant tumors. We report here that a patient with primary ependymoma of the ovary, who was resistant to BEP therapy, achieved a complete response to a combined therapy, including TIP therapy as the second-line chemotherapy and surgery. This important case, combined with published studies, suggests that TIP therapy is effective for both testicular and ovarian malignant tumors and indicates that TIP therapy can be used as an effective second-line therapy for malignant tumors resistant to BEP therapy.

KW - bleomycin, etoposide, and cisplatin

KW - ependymoma

KW - malignant germ cell tumors

KW - paclitaxel, ifosfamide, and cisplatin

KW - salvage

UR - http://www.scopus.com/inward/record.url?scp=84992468345&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84992468345&partnerID=8YFLogxK

U2 - 10.1111/jog.13084

DO - 10.1111/jog.13084

M3 - Article

VL - 42

SP - 1613

EP - 1617

JO - Asia-Oceania Journal of Obstetrics and Gynaecology

JF - Asia-Oceania Journal of Obstetrics and Gynaecology

SN - 1341-8076

IS - 11

ER -